$1.49 Million is the total value of Cormorant Asset Management, LP's 73 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 21.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXDX | Buy | PROMETHEUS BIOSCIENCES INC | $229,900 | -99.8% | 2,090,000 | +5.6% | 15.38% | +88.5% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $81,540 | -99.9% | 1,576,872 | +6.7% | 5.46% | -22.7% |
| Sell | ARCELLX INC | $64,284 | -99.9% | 2,075,000 | -31.9% | 4.30% | +7.6% | |
| MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $63,683 | -99.9% | 6,065,001 | 0.0% | 4.26% | +29.5% | ||
| RNA | Buy | AVIDITY BIOSCIENCES INC | $61,291 | -99.8% | 2,762,115 | +37.3% | 4.10% | +78.5% |
| AVTE | Sell | AEROVATE THERAPEUTICS INC | $57,344 | -99.9% | 1,957,132 | -16.0% | 3.84% | +42.1% |
| DSGN | Buy | DESIGN THERAPEUTICS INC | $52,839 | -99.9% | 5,150,000 | +3.0% | 3.54% | -39.5% |
| Buy | ERASCA INC | $46,605 | -99.9% | 10,813,246 | +2.9% | 3.12% | -45.5% | |
| RVMD | Sell | REVOLUTION MEDICINES INC | $45,140 | -99.9% | 1,895,066 | -5.0% | 3.02% | +9.9% |
| ALT | Sell | ALTIMMUNE INC | $42,770 | -99.9% | 2,600,000 | -24.5% | 2.86% | -6.9% |
| Buy | VENTYX BIOSCIENCES INC | $35,434 | -99.9% | 1,080,643 | +38.4% | 2.37% | +24.5% | |
| ETNB | New | 89BIO INC | $32,462 | – | 2,550,000 | +100.0% | 2.17% | – |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $32,131 | -99.9% | 1,100,000 | -16.0% | 2.15% | +14.5% |
| BCAB | Buy | BIOATLA INC | $30,363 | -99.8% | 3,680,365 | +68.7% | 2.03% | +73.1% |
| TANGO THERAPEUTICS INC | $29,848 | -99.8% | 4,116,949 | 0.0% | 2.00% | +91.7% | ||
| BMEA | BIOMEA FUSION INC | $26,730 | -99.9% | 3,170,872 | 0.0% | 1.79% | -17.5% | |
| EWTX | Sell | EDGEWISE THERAPEUTICS INC | $26,345 | -99.9% | 2,946,887 | -3.4% | 1.76% | -16.0% |
| SRPT | SAREPTA THERAPEUTICS INC | $25,916 | -99.9% | 200,000 | 0.0% | 1.73% | +12.2% | |
| TARS | Sell | TARSUS PHARMACEUTICALS INC | $25,456 | -99.9% | 1,736,422 | -11.9% | 1.70% | -27.8% |
| AXSM | New | AXSOME THERAPEUTICS INC | $25,067 | – | 325,000 | +100.0% | 1.68% | – |
| Buy | ASTRIA THERAPEUTICS INC | $24,569 | -99.8% | 1,650,000 | +37.5% | 1.64% | +116.9% | |
| RAIN | Buy | RAIN ONCOLOGY INC | $23,829 | -99.8% | 2,978,660 | +28.0% | 1.60% | +100.9% |
| GLUE | Sell | MONTE ROSA THERAPEUTICS INC | $22,021 | -99.9% | 2,893,717 | -3.3% | 1.47% | -13.8% |
| VECT | VECTIVBIO HLDG AG | $21,980 | -99.9% | 2,536,617 | 0.0% | 1.47% | +38.3% | |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $21,615 | -99.9% | 110,000 | -26.7% | 1.45% | -38.7% |
| Sell | AMYLYX PHARMACEUTICALS INC | $20,323 | -99.9% | 550,000 | -9.8% | 1.36% | +13.3% | |
| AXNX | AXONICS INC | $20,150 | -99.9% | 322,240 | 0.0% | 1.35% | -15.1% | |
| CABA | Buy | CABALETTA BIO INC | $18,239 | -97.6% | 1,971,739 | +70.8% | 1.22% | +2246.2% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $18,124 | -100.0% | 400,000 | -30.4% | 1.21% | -56.8% |
| RCKT | ROCKET PHARMACEUTICALS INC | $16,998 | -99.9% | 868,550 | 0.0% | 1.14% | +17.3% | |
| PCVX | New | VAXCYTE INC | $15,584 | – | 325,000 | +100.0% | 1.04% | – |
| PLRX | PLIANT THERAPEUTICS INC | $15,131 | -99.9% | 782,788 | 0.0% | 1.01% | -11.5% | |
| New | PRIME MEDICINE INC | $13,644 | – | 734,350 | +100.0% | 0.91% | – | |
| CYTK | CYTOKINETICS INC | $13,563 | -99.9% | 296,000 | 0.0% | 0.91% | -9.4% | |
| IMMUNEERING CORP | $11,088 | -100.0% | 2,286,181 | 0.0% | 0.74% | -67.6% | ||
| Sell | GREENLIGHT BIOSCIENCS HLDS P | $10,843 | -100.0% | 9,188,659 | -10.5% | 0.73% | -56.4% | |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $10,433 | -99.9% | 1,369,179 | -6.8% | 0.70% | -31.6% |
| COGT | Sell | COGENT BIOSCIENCES INC | $10,404 | -100.0% | 900,000 | -37.9% | 0.70% | -54.0% |
| STOK | STOKE THERAPEUTICS INC | $10,040 | -99.9% | 1,087,807 | 0.0% | 0.67% | -31.1% | |
| ARQT | Sell | ARCUTIS BIOTHERAPEUTICS INC | $9,620 | -99.9% | 650,000 | -35.0% | 0.64% | -51.8% |
| PHVS | Sell | PHARVARIS N V | $9,185 | -99.9% | 816,460 | -32.4% | 0.62% | -4.9% |
| VIGIL NEUROSCIENCE INC | $7,710 | -99.9% | 616,786 | 0.0% | 0.52% | +31.6% | ||
| AVIR | ATEA PHARMACEUTICALS INC | $7,442 | -99.9% | 1,547,181 | 0.0% | 0.50% | -19.0% | |
| IMVT | New | IMMUNOVANT INC | $7,100 | – | 400,000 | +100.0% | 0.48% | – |
| ALXO | Sell | ALX ONCOLOGY HLDGS INC | $6,898 | -99.9% | 612,079 | -14.0% | 0.46% | -2.9% |
| LBPH | LONGBOARD PHARMACEUTICALS IN | $6,906 | -99.9% | 2,118,283 | 0.0% | 0.46% | -16.2% | |
| VERV | Sell | VERVE THERAPEUTICS INC | $6,773 | -100.0% | 350,000 | -41.7% | 0.45% | -68.6% |
| ALT | New | ALTIMMUNE INCcall | $6,580 | – | 400,000 | +100.0% | 0.44% | – |
| VKTX | New | VIKING THERAPEUTICS INC | $6,580 | – | 700,000 | +100.0% | 0.44% | – |
| IDYA | Sell | IDEAYA BIOSCIENCES INC | $6,360 | -99.9% | 350,000 | -16.3% | 0.43% | -2.3% |
| ASND | ASCENDIS PHARMA A/Ssponsored adr | $6,107 | -99.9% | 50,000 | 0.0% | 0.41% | +13.3% | |
| PSTX | Sell | POSEIDA THERAPEUTICS INC | $6,095 | -99.9% | 1,150,000 | -37.8% | 0.41% | -10.5% |
| GHRS | GH RESEARCH PLCordinary shares | $5,764 | -99.9% | 593,043 | 0.0% | 0.39% | -19.9% | |
| ACET | Sell | ADICET BIO INC | $5,364 | -100.0% | 600,000 | -57.1% | 0.36% | -74.2% |
| AMAM | AMBRX BIOPHARMA INCsponsored ads | $5,304 | -99.8% | 2,336,389 | 0.0% | 0.36% | +101.7% | |
| ICOSAVAX INC | $5,112 | -99.7% | 643,825 | 0.0% | 0.34% | +140.8% | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $5,101 | -99.9% | 2,082,000 | 0.0% | 0.34% | -15.2% | |
| KROS | KEROS THERAPEUTICS INC | $4,802 | -99.9% | 100,000 | 0.0% | 0.32% | +22.1% | |
| ELDN | Sell | ELEDON PHARMACEUTICALS INC | $2,777 | -99.9% | 1,217,882 | -0.5% | 0.19% | -21.2% |
| ELEV | ELEVATION ONCOLOGY INC | $1,854 | -99.9% | 1,952,032 | 0.0% | 0.12% | -19.5% | |
| CNTA | Sell | CENTESSA PHARMACEUTICALS PLCsponsored ads | $1,741 | -100.0% | 561,600 | -71.5% | 0.12% | -79.1% |
| XFOR | Buy | X4 PHARMACEUTICALS INC | $1,618 | -99.9% | 1,628,980 | +96.1% | 0.11% | +9.1% |
| GLTO | GALECTO INC | $1,173 | -99.9% | 1,020,238 | 0.0% | 0.08% | -42.2% | |
| New | BIOHAVEN LTD | $1,138 | – | 81,963 | +100.0% | 0.08% | – | |
| CMMB | CHEMOMAB THERAPEUTICS LTDsponsored ads | $922 | -99.9% | 288,169 | 0.0% | 0.06% | +24.0% | |
| TALS | TALARIS THERAPEUTICS INC | $919 | -100.0% | 900,649 | 0.0% | 0.06% | -63.3% | |
| Sell | PYXIS ONCOLOGY INC | $896 | -99.9% | 668,854 | -0.0% | 0.06% | -34.8% | |
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $745 | -99.9% | 392,167 | 0.0% | 0.05% | -15.3% | |
| YMAB | Y-MABS THERAPEUTICS INC | $732 | -100.0% | 150,000 | 0.0% | 0.05% | -67.5% | |
| GRPH | GRAPHITE BIO INC | $662 | -99.9% | 199,547 | 0.0% | 0.04% | 0.0% | |
| HARP | HARPOON THERAPEUTICS INC | $392 | -99.9% | 540,600 | 0.0% | 0.03% | -29.7% | |
| BCEL | ATRECA INC | $255 | -99.9% | 319,057 | 0.0% | 0.02% | -51.4% | |
| ORTX | ORCHARD THERAPEUTICS PLCspon ads | $95 | -99.9% | 256,649 | 0.0% | 0.01% | -33.3% | |
| IMV | Exit | IMV INC | $0 | – | -234,374 | -100.0% | -0.01% | – |
| Exit | GELESIS HLDGS INC | $0 | – | -626,107 | -100.0% | -0.05% | – | |
| AKUS | Exit | AKOUOS INC | $0 | – | -394,500 | -100.0% | -0.19% | – |
| Exit | TYRA BIOSCIENCES INC | $0 | – | -743,988 | -100.0% | -0.46% | – | |
| ISEE | Exit | IVERIC BIO INCput | $0 | – | -500,000 | -100.0% | -0.63% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -30,000 | -100.0% | -0.68% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -184,894 | -100.0% | -1.95% | – |
| GOSS | Exit | GOSSAMER BIO INC | $0 | – | -3,198,382 | -100.0% | -2.68% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| QUOTIENT LTD | 30 | Q3 2021 | 4.3% |
| ASCENDIS PHARMA A/S | 30 | Q4 2022 | 4.8% |
| MINERVA NEUROSCIENCES INC | 29 | Q3 2021 | 4.4% |
| ACCELERON PHARMA INC | 28 | Q2 2021 | 3.4% |
| OMEROS CORP | 27 | Q3 2021 | 6.5% |
| MIRATI THERAPEUTICS INC | 25 | Q4 2022 | 7.6% |
| BLUEPRINT MEDICINES CORP | 25 | Q3 2021 | 3.6% |
| APELLIS PHARMACEUTICALS INC | 24 | Q3 2023 | 8.6% |
| NEUROCRINE BIOSCIENCES INC | 24 | Q1 2020 | 4.6% |
| ROCKET PHARMACEUTICALS, INC | 23 | Q3 2023 | 2.4% |
View Cormorant Asset Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ambrx Biopharma Inc. | March 13, 2023 | 42,771,365 | - |
| Altimmune, Inc. | February 14, 2023 | 2,600,000 | - |
| Arcellx, Inc. | February 14, 2023 | 2,075,000 | - |
| BioAtla, Inc. | February 14, 2023 | 2,499,250 | - |
| Eledon Pharmaceuticals, Inc. | February 14, 2023 | 1,391,663 | - |
| GreenLight Biosciences Holdings, PBC | February 14, 2023 | 4,751,020 | - |
| Prometheus Biosciences, Inc. | February 14, 2023 | 700,000 | - |
| Tango Therapeutics, Inc. | February 14, 2023 | 1,000,000 | - |
| VectivBio Holding AG | February 14, 2023 | 1,515,087 | - |
| Viridian Therapeutics, Inc.\DE | February 14, 2023 | 1,100,000 | - |
View Cormorant Asset Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-22 |
| SC 13G/A | 2024-04-15 |
| 4 | 2024-04-03 |
| SC 13G | 2024-03-21 |
| 4 | 2024-03-18 |
| SC 13G/A | 2024-03-18 |
| 4 | 2024-03-11 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Cormorant Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.